Assessing and reporting heterogeneity in treatment effects in clinical trials: a proposal
Assessing and reporting heterogeneity in treatment effects in clinical trials: a proposal
About this item
Full title
Author / Creator
Publisher
England: BioMed Central
Journal title
Language
English
Formats
Publication information
Publisher
England: BioMed Central
Subjects
More information
Scope and Contents
Contents
Mounting evidence suggests that there is frequently considerable variation in the risk of the outcome of interest in clinical trial populations. These differences in risk will often cause clinically important heterogeneity in treatment effects (HTE) across the trial population, such that the balance between treatment risks and benefits may differ s...
Alternative Titles
Full title
Assessing and reporting heterogeneity in treatment effects in clinical trials: a proposal
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_02000dbdcb5041a1868a0976c6313cc0
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_02000dbdcb5041a1868a0976c6313cc0
Other Identifiers
ISSN
1745-6215
E-ISSN
1745-6215
DOI
10.1186/1745-6215-11-85
